1. Home
  2. INZY vs KEQU Comparison

INZY vs KEQU Comparison

Compare INZY & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • KEQU
  • Stock Information
  • Founded
  • INZY 2015
  • KEQU 1906
  • Country
  • INZY United States
  • KEQU United States
  • Employees
  • INZY N/A
  • KEQU N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • KEQU Medical Specialities
  • Sector
  • INZY Health Care
  • KEQU Industrials
  • Exchange
  • INZY Nasdaq
  • KEQU Nasdaq
  • Market Cap
  • INZY 188.2M
  • KEQU 183.3M
  • IPO Year
  • INZY 2020
  • KEQU N/A
  • Fundamental
  • Price
  • INZY $1.72
  • KEQU $55.20
  • Analyst Decision
  • INZY Strong Buy
  • KEQU
  • Analyst Count
  • INZY 8
  • KEQU 0
  • Target Price
  • INZY $17.75
  • KEQU N/A
  • AVG Volume (30 Days)
  • INZY 666.9K
  • KEQU 37.3K
  • Earning Date
  • INZY 11-05-2024
  • KEQU 03-05-2025
  • Dividend Yield
  • INZY N/A
  • KEQU N/A
  • EPS Growth
  • INZY N/A
  • KEQU 168.79
  • EPS
  • INZY N/A
  • KEQU 6.31
  • Revenue
  • INZY N/A
  • KEQU $199,637,000.00
  • Revenue This Year
  • INZY N/A
  • KEQU N/A
  • Revenue Next Year
  • INZY N/A
  • KEQU N/A
  • P/E Ratio
  • INZY N/A
  • KEQU $9.15
  • Revenue Growth
  • INZY N/A
  • KEQU N/A
  • 52 Week Low
  • INZY $1.62
  • KEQU $27.00
  • 52 Week High
  • INZY $7.80
  • KEQU $67.20
  • Technical
  • Relative Strength Index (RSI)
  • INZY 23.86
  • KEQU 50.77
  • Support Level
  • INZY $2.68
  • KEQU $58.59
  • Resistance Level
  • INZY $3.18
  • KEQU $62.63
  • Average True Range (ATR)
  • INZY 0.28
  • KEQU 3.98
  • MACD
  • INZY -0.08
  • KEQU -1.05
  • Stochastic Oscillator
  • INZY 6.71
  • KEQU 19.84

About INZY Inozyme Pharma Inc.

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Share on Social Networks: